BioAscent Reports Promising Growth As It Marks Tenth AnniversarySteve Jarvis2024-11-28T14:23:27+00:00April 15th, 2024|BioCity Glasgow, Investment, News|
Scotland’s Thriving Life Sciences Sector Defies PredictionsSteve Jarvis2024-03-21T15:55:33+00:00March 21st, 2024|BioCity Glasgow, Edinburgh Technopole, Investment, News|
BioCity Glasgow: BioAscent Invests In New State-Of-The-Art Protein Production FacilitySteve Jarvis2024-11-28T14:25:44+00:00February 23rd, 2024|BioCity Glasgow, Investment, News|
Virax Biolabs Group Establishes R&D Facility At Pioneer Group’s BioCity GlasgowVicky Coghlan2024-11-28T14:36:01+00:00August 24th, 2023|BioCity Glasgow, News|
How Creative Incubation Supports Life Sciences In The UKSteve Jarvis2024-11-28T14:38:23+00:00July 13th, 2023|Accelerator, BioCity Glasgow, Investment, News|
Pioneer Group Secures Planning Permission For 72,800 sq. ft. Of Lab Space In GlasgowGemma Cann2024-12-02T12:38:34+00:00June 26th, 2023|BioCity Glasgow|
Commercializing The Success Of Scottish Life Sciences Will Rely On Scale-Up Space And Government DirectionSteve Jarvis2024-11-28T14:19:20+00:00June 14th, 2023|Article, BioCity Glasgow, Edinburgh Technopole, Investment|
Amphista Therapeutics Enters Strategic Collaboration With Bristol Myers SquibbGemma Cann2024-11-28T14:54:56+00:00May 4th, 2022|BioCity Glasgow, Investment, News|
Invizius Awarded Second Biomedical Catalyst GrantGemma Cann2022-06-30T11:30:18+01:00April 26th, 2022|BioCity Glasgow, News|
Invizius Awarded Major Biomedical Catalyst GrantGemma Cann2022-06-30T11:33:29+01:00April 1st, 2022|BioCity Glasgow, News|
